Mobile

A PHASE 2 EFFICACY AND SAFETY STUDY OF SU011248 IN COMBINATION WITH TRASTUZUMAB AS TREATMENT FOR METASTATIC DISEASE IN PATIENTS WITH BREAST CANCER

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-003773-25

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To estimate the objective response rate (ORR) for the combination of trastuzumab and SU011248 in locally recurrent or metastatic BC

Critère d'inclusion

  • locally recurrent or metastatic BC

Liens